<DOC>
	<DOCNO>NCT00277498</DOCNO>
	<brief_summary>To demonstrate statistical superiority combination latanoprost timolol individual therapy latanoprost timolol base intraocular pressure measurement 8 AM , 10 AM , 4 PM week 2 , 6 12 .</brief_summary>
	<brief_title>A 12-week , Randomized , Double-masked , Parallel Group Comparison Evening Dosing With Xalacom Subjects With Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Uni bilateral diagnosis primary open angle glaucoma ocular hypertension betablocker monotherapy dual therapy least one medication betablocker least 4 week prior screen Closed/ barely open anterior chamber angle history acute angle closure glaucoma . History ALT ( Argon Laser Trabeculoplasty ) SLT ( selective Laser ) within 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>